Omega-3 for Health & Longevity

Created on 11/15/2026 – Quick Reference based on Evidence Review created using AI4L + evidence-mcp / Opus 5.5 – Audit

Omega-3 fats, sold as fish oil or algal oil supplements and as prescription medications, are used for heart, brain and healthy-aging goals. They reliably lower blood fats. A purified high-dose form reduced heart events in people on cholesterol-lowering drugs, but other trials did not, so heart protection remains contested. Low-dose use appears well tolerated with limited proven gains; higher doses bring a heart rhythm risk that rises with dose. (Full Review)

Protocol

General health dose
About 1 g/day EPA plus DHA
VITAL used 840 mg/day as one daily capsule
Omega-3 Index–guided dosing
Index of 8% or higher
Practitioner target; dose needs scale with body weight
High-dose EPA for high triglycerides with cardiovascular risk
Icosapent ethyl 4 g/day
2 g twice daily with meals, on statin therapy
Time to effect
Triglycerides
Within weeks
Largest fall when baseline triglycerides are high
Cardiovascular effects
Over years
REDUCE-IT benefits accrued over a median 4.9 years of continuous use
Omega-3 Index
About five months
Rose more with higher daily doses

Benefits

Contraindications
  • Known hypersensitivity to a prescription omega-3 product or its components (absolute contraindication)
  • Paroxysmal or persistent atrial fibrillation (prescription doses around 4 g/day)
  • Fish or shellfish allergy (fish- and krill-derived products)
  • Active bleeding or inherited bleeding disorders (high-dose EPA)
Key Interactions
  • Anticoagulants (warfarin; apixaban unstudied): possible additive bleeding; INR monitoring
  • Antiplatelet drugs (aspirin, including over-the-counter low-dose): increased bleeding
  • Clopidogrel (platelet function): possibly stronger platelet inhibition
  • Statins (atorvastatin): no clinical effect shown
  • Antihypertensives (blood pressure drugs; propranolol): additive lowering possible
  • Meal fat content (other intervention): about one-third the uptake with a low-fat meal
  • Orlistat (weight-loss drug blocking fat digestion): lower absorption of standard oils
Theoretical (inferred from mechanism)
  • Nonsteroidal anti-inflammatory drugs (over-the-counter pain relievers; ibuprofen): more bruising or gastrointestinal bleeding
  • Supplements with antiplatelet activity (ginkgo, high-dose vitamin E): easier bruising or bleeding
  • Vitamin A supplements with cod liver oil: vitamin A excess

Risk & Side Effects

  • High: Atrial fibrillation, gastrointestinal adverse effects, LDL cholesterol rise with DHA-containing products, prolonged pregnancy
  • Medium: Bleeding, peripheral edema, musculoskeletal and joint pain, gout, oropharyngeal pain
  • Low: Prostate cancer, new depression in older adults, hypersensitivity and skin reactions, liver enzyme rises, cardiac death in angina
  • Speculative: Harm from oxidized oil

Monitoring

Marker Target Why
Omega-3 Index ≥8% Confirms adequate dosing
Triglycerides <150 mg/dL Main lipid effect
LDL cholesterol <100 mg/dL Safety check; DHA products can raise it
Blood pressure <120/80 mm Hg Expected to change modestly at 2–3 g/day
Heart rhythm (pulse or ECG) No established target; track new irregularity versus baseline Safety check for atrial fibrillation
INR (warfarin users) 2.0–3.0 Safety check for bleeding

Cadence: Omega-3 Index and lipid panel at about 3–4 months, then every 6–12 months once stable; INR 1–2 weeks after starting alongside warfarin; blood pressure monthly during dose increases

Qualitative Assessment

  • Gastrointestinal tolerance (belching, indigestion, stool changes)
  • Joint stiffness and pain, particularly in inflammatory arthritis
  • Mood and energy, especially in older adults
  • Palpitations or irregular heartbeat
  • Easy bruising, nosebleeds or prolonged bleeding from cuts